Quantcast

Latest Paracetamol Stories

2014-06-25 23:08:04

Transparency Market Research has announced the addition of the "Pain Management Therapeutics Market: Global Industry Analysis, Size, Share, Growth and Forecast 2012 - 2018" report to their offering. Browse the full report: http://www.transparencymarketresearch.com/pain-management-therapeutics.html. Albany, New York (PRWEB) June 25, 2014 The global pain management therapeutics market is expected to witness a decline during the forecast period (2012 to 2018) due to patent...

2014-06-19 23:02:52

The Firm is investigating Tylenol lawsuits on behalf of individuals who allegedly suffered severe liver damage due to acetaminophen, the active ingredient in Tylenol over-the-counter medications. New York, New York (PRWEB) June 19, 2014 A Tylenol lawsuit (http://www.tylenollawsuitclaims.com/ ) involving the alleged wrongful death of an infant will be allowed to proceed after a federal judge ruled that Nevada’s discovery rule would apply to the case, Bernstein Liebhard LLP reports. The...

2014-06-12 23:02:38

The Firm is evaluating Tylenol lawsuits on behalf of individuals who allegedly suffered severe liver damage due to acetaminophen in over-the-counter Tylenol products. New York, New York (PRWEB) June 12, 2014 Tylenol lawsuits http://www.tylenollawsuitclaims.com/) filed on behalf of individuals who allegedly suffered severe liver damage due to the acetaminophen in over-the-counter Tylenol products continue to move forward in the U.S. District Court, Eastern District of Pennsylvania,...

2014-06-11 12:29:06

PITTSBURGH, June 11, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Risedronate Sodium Tablets USP, 150 mg, the generic version of Warner Chilcott's Actonel(®) Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment and prevention of osteoporosis in postmenopausal women. Risedronate Sodium Tablets USP, 150 mg, had...

2014-06-10 23:00:59

The Firm is investigating Tylenol lawsuits on behalf of patients who allegedly suffered acetaminophen-induced liver damage due to their use of Tylenol-brand over-the-counter medications. New York, New York (PRWEB) June 10, 2014 As Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) continue to mount in U.S. courts, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) has issued yet another caution regarding the potential for acetaminophen, the active...

2014-06-09 08:29:12

Data Presented from Company's Pain, Cancer Immunotherapy, and Inappetence Programs KANSAS CITY, Kan., June 9, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion animals, today announced findings from the company's ongoing safety and clinical programs, which were presented at the 2014 American College of Veterinary...

2014-06-03 08:32:29

Multi-Tranche Financing Provides Sufficient Funding to Take KP201 Through and Beyond Potential FDA Approval and Enables KemPharm to Advance its Full Pipeline of Abuse-Deterrent Prodrugs CORALVILLE, Iowa, June 3, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that it has entered into a $60 million financing agreement with an investment fund managed by...

2014-05-29 08:29:40

MISSISSAUGA, ON, May 29, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products today announced that a third party has received U.S. Food and Drug Administration (FDA) approval to market and sell a topical diclofenac sodium 1.5% solution in the United States. The product is a generic version of Nuvo's PENNSAID (diclofenac sodium topical solution) 1.5% w/w (PENNSAID 1.5%). Mallinckrodt Inc. (NYSE:MNK)...

2014-05-29 08:29:06

PITTSBURGH, May 29, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Atovaquone and Proguanil Hydrochloride Tablets, 62.5 mg/25 mg and 250 mg/100 mg, the generic version of GlaxoSmithKline's Malarone(®) Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the prophylaxis of Plasmodium falciparum malaria and the treatment of...

2014-05-26 23:02:58

The Firm is actively investigating Tylenol liver damage lawsuits on behalf of individuals allegedly injured by acetaminophen, the over-the-counter pain reliever’s active ingredient. New York, NY (PRWEB) May 26, 2014 A number of additional Tylenol lawsuits (http://www.tylenollawsuitclaims.com/ ) alleging liver damage have been filed in a federal litigation currently underway in the U.S. District Court, District of Eastern Pennsylvania over the past month, Bernstein Liebhard LLP reports....


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related